PainChek (ASX:PCK) said its contracted annual recurring revenue rose 10% to AU$5.4 million in the June quarter, according to a Thursday Australian bourse filing.

The company's net contracted licenses increased 9% to 110,000 over the period, while the net license retention rate came in at 106%, the filing said.

The company attributed the rise in licenses and annual recurring revenue to its expansion strategies and new customer acquisitions, including in the UK, Australia, and Canada.

PainChek's shares were down almost 5% at market close Thursday.